Intratumoral injection of taxol in vivo suppresses A549 tumor showing cytoplasmic vacuolization

Journal of Cellular Biochemistry

Volumn 113, Issue 4, 2012, Pages 1397-1406

  Wang, Chaoyang ^a   Chen, Tongsheng ^a  

^a SOUTH CHINA NORMAL UNIVERSITY   (China)

Author keywords

A549 CELLS; APOPTOSIS; CYTOPLASMIC VACUOLIZATION; ENDOPLASMIC RETICULUM (ER); INTRATUMORAL INJECTION; ONCONSIS; PARAPTOSIS LIKE CELL DEATH; SENESCENCE; TAXOL

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; BETA GALACTOSIDASE; CASPASE 3; PACLITAXEL; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL XL; PROTEIN MCL 1; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL AGING; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOLYSIS; CYTOPLASM VESICLE; CYTOTOXICITY; DNA FRAGMENTATION; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION SWELLING; MOUSE; NONHUMAN; PARAPTOSIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; TIME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BASE SEQUENCE; CELL DEATH; CELL LINE, TUMOR; CYTOPLASM; DNA PRIMERS; HUMANS; INJECTIONS, INTRALESIONAL; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; PACLITAXEL; TRANSPLANTATION, HETEROLOGOUS; VACUOLES;

MUS;

EID: 84863127107     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24012     Document Type: Article

References (47)

1. Al-Ghananeem AM, Malkawi AH, Muammer YM, Balko JM, Black EP, Mourad W, Romond E,. 2009. Intratumoral delivery of paclitaxel in solid tumor from biodegradable hyaluronan nanoparticle formulations. AAPS Pharm Sci Tech 10: 410-417.
2. Cao X, Zhang Y, Zou L, Xiao H, Chu Y, Chu X,. 2010. Persistent oxygen-glucose deprivation induces astrocytic death through two different pathways and calpain-mediated proteolysis of cytoskeletal proteins during astrocytic oncosis. Neurosci Lett 479: 118-122.
3. Celikoglu F, Celikoglu SI, Goldberg EP,. 2008. Bronchoscopic intratumoral chemotherapy of lung cancer. Lung Cancer 61: 1-12.
4. Chang BD, Broude EV, Dokmanovic M, Zhu H, Ruth A, Xuan Y, Kandel ES, Lausch E, Christov K, Roninson IB,. 1999. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 59: 3761-3767.
5. Chen TS, Wang XP, Sun L, Wang LX, Xing D, Mok M,. 2008. Taxol induces caspase-independent cytoplasmic vacuolization and cell death through endoplasmic reticulum (ER) swelling in ASTC-a-1cells. Cancer Lett 270: 164-172.
6. Crown J, O'Leary M, Ooi WS,. 2004. Docetaxel and paclitaxel in the treatment of breast cancer: A review of clinical experience. Oncologist 9 (Suppl 2): 24-32.
7. Duncan EL, Reddel RR,. 1997. Genetic changes associated with immortalization. Biochemistry 62: 1263-1274.
8. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J,. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367.
9. Ding WX, Ni HM, Yin XM,. 2007. Absence of Bax switched MG132-induced apoptosis to non-apoptotic cell death that could be suppressed by transcriptional or translational inhibition. Apoptosis 12: 2233-2244.
10. Fields AL, Runowicz CD,. 2003. Current therapies in ovarian cancer. Cancer Invest 21: 148-156.
11. 2 stress triggers a release of transforming growth factor-β1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J Biol Chem 276: 2531-2537.
12. Guo WJ, Chen TS, Wang XP, Chen R,. 2010. Taxol induces concentration-dependent apoptotic and paraptosis-like cell death in human lung adenocarcinoma (ASTC-a-1) cells. J X-ray Sci Technol 18: 293-308.
13. Hayflick L, Moorhead PS,. 1961. The serial cultivation of human diploid cell strains. Exp Cell Res 37: 585-621.
14. Hocsak E, Racz B, Szabo A, Pozsgai E, Szigeti A, Szigeti E, Gallyas F Jr, Sumegi B, Javor S, Bellyei S,. 2010. TIP47 confers resistance to taxol-induced cell death by preventing the nuclear translocation of AIF and Endonuclease G. Eur J Cell Biol 89: 853-861.
15. Horwitz SB, Cohen D, Rao S, Ringel I, Shen HJ, Yang CP,. 1993. Taxol: Mechanisms of action and resistance. J Natl Cancer Inst Monogr 15: 55-61.
16. Hu W, Kavanagh JJ,. 2003. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 4: 721-729.
17. Ishibashi M, Nakayama K, Yeasmin S, Katagiri A, Iida K, Nakayama N, Fukumoto M, Miyazaki K,. 2008. A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for taxol resistance in ovarian cancer. Clin Cancer Res 14: 3149-3155.
18. Isoldi MC, Visconti MA, Castrucci AM,. 2005. Anti-cancer drugs: Molecular mechanisms of action. Mini Rev Med Chem 5: 685-695.
19. Jackson JK, Gleave ME, Yago V, Beraldi E, Hunter WL, Burt HM,. 2000. The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel. Cancer Res 60: 4146-4151.
20. Klee M, Pimentel-Muiños FX,. 2005. Bcl-XL specifically activates Bak to induce swelling and restructuring of the endoplasmic reticulum. J Cell Biol 168: 723-734.
21. Li YL, Xing D, Chen Q,. 2009. Dynamic monitoring of apoptosis in chemotherapies with multiple fluorescence reporters. Mol Imaging Biol 11: 213-222.
22. Liao PC, Tan SK, Lieu CH, Jung HK,. 2008. Involvement of endoplasmic reticulum in paclitaxel-induced apoptosis. J Cell Biochem 104: 1509-1523.
23. Loo D, Pryer N, Young P, Liang T, Coberly S, King KL, Kang K, Roberts P, Tsao M, Xu X, Potts B, Mather JP,. 2007. The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo. Mol Cancer Ther 6: 856-865.
24. Lu Y, Chen T, Wang XP, Qu JL, Chen M,. 2010. The JNK inhibitor SP600125 enhances dihydroartemisinin-induced apoptosis by accelerating Bax translocation into mitochondria in human lung adenocarcinoma cells. FEBS Lett 584: 4019-4026.
25. Mailloux A, Grenet K, Bruneel A, BeÂneÂteau-Burnat B, Vaubourdolle M, Baudin B,. 2001. Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis. Eur J Cell Biol 80: 442-449.
26. Majno G, Joris I,. 1995. Apoptosis, oncosis, and necrosis: An overview of cell death. Am J Pathol 146: 3-15.
27. Mimnaugh EG, Xu W, Vos M, Yuan X, Isaacs JS, Bisht KS, Gius D, Neckers L,. 2004. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Mol Cancer Ther 3: 551-566.
28. Monzõ M, Rosell R, SaÂnchez JJ, Lee JS, O'Brate A, Gonzalez-Larriba JL, Alberola V, Lorenzo JC, Nunez L, Ro JY, Martin C,. 1999. Paclitaxel resistance in non-small-cell lung cancer associated with β-tubulin gene mutations. J Clin Oncol 17: 1786-1793.
29. O'Callaghan-Sunol C, Gabai VL, Sherman MY,. 2007. Hsp27 modulates p53 signaling and suppresses cellular senescence. Cancer Res 67: 11779-11788.
30. Pallis AG, Serfass L, Dziadziuszko R, van Meerbeeck JP, Fennell D, Lacombe D, Welch J, Gridelli C,. 2009. Targeted therapies in the treatment of advanced/metastatic NSCLC. Eur J Cancer 45: 2473-2487.
31. Pushkarev VM, Starenki DV, Saenko VA, Pushkarev VV, Kovzun OI, Tronko MD, Popadiuk ID, Yamashita S,. 2008. Differential effects of low and high doses of taxol in anaplastic thyroid cancer cells: Possible implication of the Pin1 prolylisomerase. Exp Oncol 30: 190-194.
32. Rabah SO,. 2010. Acute Taxol nephrotoxicity: Histological and ultrastructural studies of mice kidney parenchyma. Saudi Med J 17: 105-114.
33. Schroder M, Kaufman RJ,. 2005. The mammalian unfolded protein response. Annu Rev Biochem 74: 739-789.
34. Shikanov A, Shikanov S, Vaisman B, Golenser J, Domb AJ,. 2008. Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant. Int J Pharm 358: 114-120.
35. Shikanov S, Shikanov A, Gofrit O, Nyska A, Corn B, Domb AJ,. 2009. Intratumoral delivery of Paclitaxel for treatment of orthotopic prostate cancer. J Pharma Sci 98: 1005-1014.
36. Smith JR, Pereira-Smith OM,. 1996. Replicative senescence: Implications for in vivo aging and tumor suppression. Science 273: 63-67.
37. Sperandio S, deBelle I, Bredesen DE,. 2000. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA 97: 14376-14381.
38. Stepien A, Grzanka A, Grzanka D, Szczepanski MA, Helmin-Basa A, Gackowska L,. 2010. Taxol-induced polyploidy and cell death in CHO AA8cells. Acta Histochem 112: 62-71.
39. Sun QR, Chen TS, Wang XP, Xun BW,. 2010. Taxol induces paraptosis independent of both protein synthesis and MAPK Pathway. J Cell Physiol 222: 421-432.
40. Szanto A, Hellebrand EE, Bognar Z, Tucsek Z, Szabo A, Gallyas F, Jr, Sumegi B, Varbiro G,. 2009. PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol. Biochem Pharmacol 77: 1348-1357.
41. Szegezdi E, Fitzgerald U, Samali A,. 2003. Caspase-12 and ER-stress-mediated apoptosis: The story so far. Ann NY Acad Sci 1010: 186-194.
42. Torres K, Horwitz SB,. 1998. Mechanisms of taxol-induced cell death are concentration dependent. Cancer Res 58: 3620-3626.
43. Trump BE, Berezesky IK, Chang SH, Phelps PC,. 1997. The pathways of cell death: Oncosis, apoptosis, and necrosis. Toxicol Pathol 24: 82-88.
44. Yeung TK, Germond C, Chen XM, Wang ZX,. 1999. The mode of action of Taxol: Apoptosis at low concentration and necrosis at high concentration. Biochem Biophys Res Commun 263: 398-404.
45. Yoo GH, Subramanian G, Boinpally RR,. 2005. An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 131: 418-429.
46. Yu YL, Su KJ, Chen CJ, Wei CW, Lin CJ, Yiang GT, Lin SZ, Harn HJ, Chen YLS,. 2012. Synergistic anti-tumor activity of isochaihulactone and paclitaxel on human lung cancer cells. J Cell Physiol 227: 213-222.
47. Zaman GJ, Flens MJ, van Leusden MR, de Haas M, Mulder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ,. 1994. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91: 8822-8826.